Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Lippman

Showing results (71-80 of 240) with videos related to

Pageof 24
Sort By:
Anticancer Research|August 6, 2000
Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomasH Wu, R Lotan, D Menter, et al.
Journal of the American Dental Association (1939)|July 1, 1993
Chemoprevention as a form of cancer controlB B Toth, J W Martin, S M Lippman, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Micronuclei: a potential intermediate marker for chemoprevention of aerodigestive tract cancerS E Benner, M J Wargovich, S M Lippman, et al.
Current Opinion in Oncology|November 4, 1998
Retinoids in the chemoprevention of bladder cancerA L Sabichi, S P Lerner, H B Grossman, et al.
The Western Journal of Medicine|January 1, 1988
The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpuraS M Lippman, G E Lizak, S K Foung, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1988
Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomasS M Lippman, J R Volk, C M Spier, et al.
Cancer|February 1, 1988
Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survivalC M Spier, S M Lippman, T P Miller, et al.
Cancer Research|January 19, 1999
Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cellsJ L Clifford, D G Menter, M Wang, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 15, 2001
The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal diseaseG L Clayman, C J Johnson, W Morrison, et al.
Urology|April 11, 2001
Design considerations for efficient prostate cancer chemoprevention trialsJ J Lee, R Lieberman, J A Sloan, et al.
Pageof 24

Showing results (71-80 of 240) with videos related to

Sort By:
Pageof 24
Anticancer Research|August 6, 2000
Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomasH Wu, R Lotan, D Menter, et al.
Journal of the American Dental Association (1939)|July 1, 1993
Chemoprevention as a form of cancer controlB B Toth, J W Martin, S M Lippman, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Micronuclei: a potential intermediate marker for chemoprevention of aerodigestive tract cancerS E Benner, M J Wargovich, S M Lippman, et al.
Current Opinion in Oncology|November 4, 1998
Retinoids in the chemoprevention of bladder cancerA L Sabichi, S P Lerner, H B Grossman, et al.
The Western Journal of Medicine|January 1, 1988
The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpuraS M Lippman, G E Lizak, S K Foung, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1988
Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomasS M Lippman, J R Volk, C M Spier, et al.
Cancer|February 1, 1988
Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survivalC M Spier, S M Lippman, T P Miller, et al.
Cancer Research|January 19, 1999
Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cellsJ L Clifford, D G Menter, M Wang, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 15, 2001
The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal diseaseG L Clayman, C J Johnson, W Morrison, et al.
Urology|April 11, 2001
Design considerations for efficient prostate cancer chemoprevention trialsJ J Lee, R Lieberman, J A Sloan, et al.
Pageof 24